Email This Release
Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Delivered by Inovio Biomedical's Electroporation System Show Increased T-Cell Responses and Reduced Viral Loads
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
